Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 410

1.

Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program.

Matsumoto K, Yaegashi N, Iwata T, Yamamoto K, Aoki Y, Okadome M, Ushijima K, Kamiura S, Takehara K, Horie K, Tasaka N, Sonoda K, Takei Y, Aoki Y, Konnai K, Katabuchi H, Nakamura K, Ishikawa M, Watari H, Yoshida H, Matsumura N, Nakai H, Shigeta S, Takahashi F, Noda K, Yoshikawa H; MINT Study Group.

Cancer Sci. 2019 Oct 9. doi: 10.1111/cas.14212. [Epub ahead of print]

2.

Depth measurement of molecular permeation using inclined confocal microscopy.

Kikuchi K, Shigeta S, Ishikawa T.

PLoS One. 2019 Mar 27;14(3):e0214504. doi: 10.1371/journal.pone.0214504. eCollection 2019.

3.

La-Related Protein 4 as a Suppressor for Motility of Ovarian Cancer Cells.

Egiz M, Usui T, Ishibashi M, Zhang X, Shigeta S, Toyoshima M, Kitatani K, Yaegashi N.

Tohoku J Exp Med. 2019 Jan;247(1):59-67. doi: 10.1620/tjem.247.59.

4.

Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.

Ishibashi M, Toyoshima M, Zhang X, Hasegawa-Minato J, Shigeta S, Usui T, Kemp CJ, Grandori C, Kitatani K, Yaegashi N.

Sci Rep. 2018 Sep 4;8(1):13207. doi: 10.1038/s41598-018-31069-2.

5.

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel.

Seino M, Ohta T, Sugiyama A, Sakaki H, Sudo T, Tsutsumi S, Shigeta S, Tokunaga H, Toyoshima M, Yaegashi N, Nagase S.

Oncotarget. 2018 Aug 10;9(62):31985-31998. doi: 10.18632/oncotarget.25868. eCollection 2018 Aug 10.

6.

Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers.

Hasegawa-Minato J, Toyoshima M, Ishibashi M, Zhang X, Shigeta S, Grandori C, Kitatani K, Yaegashi N.

Oncotarget. 2017 Dec 15;9(3):3483-3496. doi: 10.18632/oncotarget.23322. eCollection 2018 Jan 9.

7.

Ceramide Nanoliposomes as a MLKL-Dependent, Necroptosis-Inducing, Chemotherapeutic Reagent in Ovarian Cancer.

Zhang X, Kitatani K, Toyoshima M, Ishibashi M, Usui T, Minato J, Egiz M, Shigeta S, Fox T, Deering T, Kester M, Yaegashi N.

Mol Cancer Ther. 2018 Jan;17(1):50-59. doi: 10.1158/1535-7163.MCT-17-0173. Epub 2017 Oct 27.

8.

Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.

Shigeta S, Nagase S, Mikami M, Ikeda M, Shida M, Sakaguchi I, Ushioda N, Takahashi F, Yamagami W, Yaegashi N, Udagawa Y, Katabuchi H.

J Gynecol Oncol. 2017 Nov;28(6):e76. doi: 10.3802/jgo.2017.28.e76.

9.

Eccrine porocarcinoma of the vulva: a case report and review of the literature.

Fujimine-Sato A, Toyoshima M, Shigeta S, Toki A, Kuno T, Sato I, Watanabe M, Niikura H, Yaegashi N.

J Med Case Rep. 2016 Nov 10;10(1):319. Review.

10.

Leptomeningeal metastasis from gynecologic cancers diagnosed by brain MRI.

Toyoshima M, Tsuji K, Shigeta S, Tokunaga H, Ito K, Watanabe Y, Yoshinaga K, Otsuki T, Niikura H, Yaegashi N.

Clin Imaging. 2017 Jan - Feb;41:42-47. doi: 10.1016/j.clinimag.2016.09.013. Epub 2016 Sep 30.

PMID:
27764719
11.

Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer.

Shigeta S, Toyoshima M, Kitatani K, Ishibashi M, Usui T, Yaegashi N.

Oncogene. 2016 Jul 7;35(27):3577-86. doi: 10.1038/onc.2015.425. Epub 2015 Nov 9.

PMID:
26549031
12.

Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid.

Kitatani K, Usui T, Sriraman SK, Toyoshima M, Ishibashi M, Shigeta S, Nagase S, Sakamoto M, Ogiso H, Okazaki T, Hannun YA, Torchilin VP, Yaegashi N.

Oncogene. 2016 May;35(21):2801-12. doi: 10.1038/onc.2015.330. Epub 2015 Sep 14.

13.

Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.

Mashiko S, Kitatani K, Toyoshima M, Ichimura A, Dan T, Usui T, Ishibashi M, Shigeta S, Nagase S, Miyata T, Yaegashi N.

Cancer Biol Ther. 2015;16(2):253-60. doi: 10.1080/15384047.2014.1001271.

14.

Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.

Takano T, Niikura H, Ito K, Nagase S, Utsunomiya H, Otsuki T, Toyoshima M, Tokunaga H, Kaiho-Sakuma M, Shiga N, Nagai T, Tanaka S, Otsuki A, Kurosawa H, Shigeta S, Tsuji K, Yamaguchi T, Yaegashi N.

Int J Clin Oncol. 2014 Oct;19(5):897-905. doi: 10.1007/s10147-013-0627-5. Epub 2013 Oct 24.

PMID:
24149774
15.

[Diagnosis and treatment of uterine leiomyosarcoma].

Shigeta S, Nagase S, Yaegashi N.

Nihon Rinsho. 2012 Jun;70 Suppl 4:452-5. Japanese. No abstract available.

PMID:
23156289
16.

Sequential liver-kidney transplantation in a boy with congenital hepatic fibrosis and nephronophthisis from a living donor.

Udagawa T, Kamei K, Ogura M, Tsutsumi A, Noda S, Kasahara M, Fukuda A, Sakamoto S, Shigeta S, Tanaka H, Kuroda T, Matsuoka K, Nakazawa A, Nagai T, Uemura O, Ito S.

Pediatr Transplant. 2012 Nov;16(7):E275-80. doi: 10.1111/j.1399-3046.2011.01611.x. Epub 2011 Nov 30.

PMID:
22129440
17.

Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway.

Takahashi M, Mori S, Shigeta S, Fujita T.

Adv Exp Med Biol. 2007;598:93-104. Review.

PMID:
17892207
18.

Dietary pulverized konjac glucomannan suppresses scratching behavior and skin inflammatory immune responses in NC/Nga mice.

Onishi N, Kawamoto S, Suzuki H, Santo H, Aki T, Shigeta S, Hashimoto K, Hide M, Ono K.

Int Arch Allergy Immunol. 2007;144(2):95-104. Epub 2007 May 24.

PMID:
17536217
19.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, Yamaguchi O, Ishibashi K, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Muratani T, Naito S, Egashira T, Konishi T, Kohno S, Hirakata Y, Kondo A, Matsuda J, Nakano M.

Jpn J Antibiot. 2006 Aug;59(4):217-315. Japanese.

PMID:
17111595
20.

Decrease in the allergenicity of Japanese cedar pollen allergen by treatment with positive and negative cluster ions.

Kawamoto S, Oshita M, Fukuoka N, Shigeta S, Aki T, Hayashi T, Nishikawa K, Ono K.

Int Arch Allergy Immunol. 2006;141(4):313-21. Epub 2006 Aug 29.

PMID:
16940742
21.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004) II. Background of patients].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, Yamaguti O, Ishibashi K, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Muratani T, Naito S, Egashira T, Konishi T, Kohno S, Hirakata Y, Kondo A, Matsuda J, Nakano M.

Jpn J Antibiot. 2006 Jun;59(3):201-13. Japanese.

PMID:
16913405
22.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, Yamaguti O, Ishibashi K, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Muratani T, Naito S, Egashira T, Konishi T, Kohno S, Hirakata Y, Kondo A, Matsuda J, Nakano M.

Jpn J Antibiot. 2006 Jun;59(3):177-200. Japanese.

PMID:
16913404
23.

Anti-RNA virus activity of polyoxometalates.

Shigeta S, Mori S, Yamase T, Yamamoto N, Yamamoto N.

Biomed Pharmacother. 2006 Jun;60(5):211-9. Epub 2006 May 24.

PMID:
16737794
24.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). III. Secular changes in susceptibility].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Hirose T, Sato S, Shigeta S, Fujime M, Fujita K, Yamaguti O, Ishibashi K, Igari J, Suzutani T, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Furuya N, Murai M, Deguchi T, Ishihara S, Ooe H, Matsumoto T, Takahashi K, Nishikawa M, Naito S, Egashira T, Konishi T, Oka T, Kitamura M, Kohno S, Fukuhara Y, Hirakata Y, Kondo A, Matsuda J, Nakano M, Kamidono S, Suzuki Y, Arakawa S, Kumon H, Monden K.

Jpn J Antibiot. 2005 Dec;58(6):557-654. Japanese.

PMID:
16521346
25.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). II. Background of patients].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Yamaguti O, Ishibashi K, Hirose T, Suzutani T, Shigeta S, Yoshida H, Imafuku Y, Murai M, Oka T, Kitamura M, Watanabe K, Kobayashi Y, Uchida H, Fukuhara Y, Matsuda S, Kamidono S, Sato S, Arakawa S, Fujime M, Fujita K, Kumon H, Monden K, Igari J, Matsumoto T, Takahashi K, Oguri T, Naito S, Egashira T, Konishi T, Yamaguchi K, Furuya N, Kohno S, Deguchi T, Ishihara S, Hirakata Y, Kondo A, Matsuda J, Nakano M, Ooe H, Suzuki Y, Nishikawa M.

Jpn J Antibiot. 2005 Dec;58(6):544-56. Japanese.

PMID:
16521345
26.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). I. Susceptibility distribution].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Hirose T, Sato S, Shigeta S, Fujime M, Fujita K, Yamaguti O, Ishibashi K, Igari J, Suzutani T, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Furuya N, Murai M, Deguchi T, Ishihara S, Ooe H, Matsumoto T, Takahashi K, Nishikawa M, Naito S, Egashira T, Konishi T, Oka T, Kitamura M, Kohno S, Fukuhara Y, Hirakata Y, Kondo A, Matsuda J, Nakano M, Kamidono S, Suzuki Y, Arakawa S, Kumon H, Monden K.

Jpn J Antibiot. 2005 Dec;58(6):518-43. Japanese.

PMID:
16521344
27.

Production of two types of phytase from Aspergillus oryzae during industrial koji making.

Fujita J, Shigeta S, Yamane Y, Fukuda H, Kizaki Y, Wakabayashi S, Ono K.

J Biosci Bioeng. 2003;95(5):460-5.

PMID:
16233440
28.

Extracellular secretion of free fatty acids by disruption of a fatty acyl-CoA synthetase gene in Saccharomyces cerevisiae.

Michinaka Y, Shimauchi T, Aki T, Nakajima T, Kawamoto S, Shigeta S, Suzuki O, Ono K.

J Biosci Bioeng. 2003;95(5):435-40.

PMID:
16233436
29.

Production and properties of phytase and acid phosphatase from a sake koji mold, Aspergillus oryzae.

Fujita J, Yamane Y, Fukuda H, Kizaki Y, Wakabayashi S, Shigeta S, Suzuki O, Ono K.

J Biosci Bioeng. 2003;95(4):348-53.

PMID:
16233418
30.

Toward elucidating the full spectrum of mite allergens--state of the art.

Kawamoto S, Aki T, Yamashita M, Tategaki A, Fujimura T, Tsuboi S, Katsutani T, Suzuki O, Shigeta S, Murooka Y, Ono K.

J Biosci Bioeng. 2002;94(4):285-98.

PMID:
16233305
31.

Purification and characterization of sea squirt alpha-N-acetylgalactosaminidase.

Shigeta S, Suzuki O, Aki Y, Kawamoto S, Ono K.

J Biosci Bioeng. 2000;89(1):84-6.

PMID:
16232704
32.

Characterization of immunosuppressive factors expressed in serum by rat tolerogenic liver transplantation.

Nakano T, Kawamoto S, Lai CY, Hsu LW, Lin YC, Sasaki T, Aki T, Shigeta S, Goto T, Ohmori N, Sato S, Goto S, Ono K, Chen CL.

Transplant Proc. 2005 Jan-Feb;37(1):80-1.

PMID:
15808554
33.

Current status of anti-SARS agents.

Shigeta S, Yamase T.

Antivir Chem Chemother. 2005;16(1):23-31. Review.

PMID:
15739619
34.

Molecular cloning of a class IV chitinase allergen from Japanese cedar (Cryptomeria japonica) pollen and competitive inhibition of its immunoglobulin E-binding capacity by latex C-serum.

Fujimura T, Shigeta S, Suwa T, Kawamoto S, Aki T, Masubuchi M, Hayashi T, Hide M, Ono K.

Clin Exp Allergy. 2005 Feb;35(2):234-43.

PMID:
15725197
35.

A new immunomodulatory function of low-viscous konjac glucomannan with a small particle size: its oral intake suppresses spontaneously occurring dermatitis in NC/Nga mice.

Onishi N, Kawamoto S, Nishimura M, Nakano T, Aki T, Shigeta S, Shimizu H, Hashimoto K, Ono K.

Int Arch Allergy Immunol. 2005 Mar;136(3):258-65. Epub 2005 Feb 16.

PMID:
15722635
36.

Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives.

Masuda N, Yamamoto O, Fujii M, Ohgami T, Fujiyasu J, Kontani T, Moritomo A, Orita M, Kurihara H, Koga H, Kageyama S, Ohta M, Inoue H, Hatta T, Shintani M, Suzuki H, Sudo K, Shimizu Y, Kodama E, Matsuoka M, Fujiwara M, Yokota T, Shigeta S, Baba M.

Bioorg Med Chem. 2005 Feb 15;13(4):949-61.

PMID:
15670903
37.

The ability of konjac-glucomannan to suppress spontaneously occurring dermatitis in NC/Nga mice depends upon the particle size.

Onishi N, Kawamoto S, Nishimura M, Nakano T, Aki T, Shigeta S, Shimizu H, Hashimoto K, Ono K.

Biofactors. 2004;21(1-4):163-6.

PMID:
15630191
38.

Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.

Hosoya M, Mori S, Tomoda A, Mori K, Sawaishi Y, Kimura H, Shigeta S, Suzuki H.

Antimicrob Agents Chemother. 2004 Dec;48(12):4631-5.

39.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). III. Secular changes in susceptibility].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Yamaguti O, Ishibashi K, Shigeta S, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Nishikawa M, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Takahashi K, Naito S, Egashira T, Kohno S, Miyazaki Y, Hirakata Y, Aoki S.

Jpn J Antibiot. 2004 Aug;57(4):311-403. Japanese.

PMID:
15535040
40.

Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides.

Masuda N, Yamamoto O, Fujii M, Ohgami T, Fujiyasu J, Kontani T, Moritomo A, Orita M, Kurihara H, Koga H, Nakahara H, Kageyama S, Ohta M, Inoue H, Hatta T, Suzuki H, Sudo K, Shimizu Y, Kodama E, Matsuoka M, Fujiwara M, Yokota T, Shigeta S, Baba M.

Bioorg Med Chem. 2004 Dec 1;12(23):6171-82.

PMID:
15519161
41.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). II. Background of patients].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Yamaguti O, Ishibashi K, Shigeta S, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Nishikawa M, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Takahashi K, Naito S, Egashira T, Kohno S, Miyazaki Y, Hirakata Y, Aoki S.

Jpn J Antibiot. 2004 Jun;57(3):275-87. Japanese.

PMID:
15376786
42.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). I. Susceptibility distribution].

Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Yamaguti O, Ishibashi K, Shigeta S, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Nishikawa M, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Takahashi K, Naito S, Egashira T, Kohno S, Miyazaki Y, Hirakata Y, Aoki S.

Jpn J Antibiot. 2004 Jun;57(3):246-74. Japanese.

PMID:
15376785
43.

Liver transplantation-induced antihistone H1 autoantibodies suppress mixed lymphocyte reaction.

Nakano T, Kawamoto S, Lai CY, Sasaki T, Aki T, Shigeta S, Goto T, Sato S, Goto S, Chen CL, Ono K.

Transplantation. 2004 May 27;77(10):1595-603.

PMID:
15239628
44.

Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus.

Kimura K, Ishioka K, Hashimoto K, Mori S, Suzutani T, Bowlin TL, Shigeta S.

Antiviral Res. 2004 Mar;61(3):165-71.

PMID:
15168797
45.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). III. Secular changes in susceptibility].

Kumamoto Y, Tsukamoto T, Watanabe K, Kobayashi Y, Matsukawa M, Uchida H, Kunishima Y, Hirose T, Matsuda S, Sato S, Shigeta S, Fujime M, Fujita K, Yamaguti O, Ogihara M, Igari J, Ishibashi K, Takahashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Furuya N, Kashitani F, Murai M, Ooe H, Nishikawa M, Kumon H, Monden K, Oka T, Kitamura M, Kohno S, Tomono K, Matsuoka Y, Miyazaki Y, Fukuhara Y, Hirakata Y, Aoki S.

Jpn J Antibiot. 2003 Dec;56(6):584-673. Japanese.

PMID:
15007874
46.

Two-dimensional IgE-binding spectrum of Japanese cedar (Cryptomeria japonica) pollen allergens.

Fujimura T, Shigeta S, Kawamoto S, Aki T, Masubuchi M, Hayashi T, Yoshizato K, Ono K.

Int Arch Allergy Immunol. 2004 Feb;133(2):125-35. Epub 2004 Jan 26.

PMID:
14745225
47.

Grouping newly isolated docosahexaenoic acid-producing thraustochytrids based on their polyunsaturated fatty acid profiles and comparative analysis of 18S rRNA genes.

Huang J, Aki T, Yokochi T, Nakahara T, Honda D, Kawamoto S, Shigeta S, Ono K, Suzuki O.

Mar Biotechnol (NY). 2003 Sep-Oct;5(5):450-7.

PMID:
14730428
48.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). II. Background of patients].

Kumamoto Y, Tsukamoto T, Murai M, Matsukawa M, Kunishima Y, Watanabe K, Kobayashi Y, Uchida H, Hirose T, Shigeta S, Matsuda S, Sato S, Yamaguti O, Ogihara M, Ishibashi K, Fujime M, Fujita K, Takahashi K, Igari J, Yoshida H, Imafuku Y, Oguri T, Yamaguchi K, Furuya N, Fukuhara Y, Kashitani F, Kumon H, Monden K, Ooe H, Nishikawa M, Kohno S, Tomono K, Miyazaki Y, Oka T, Kitamura M, Hirakata Y, Aoki S, Matsuoka Y.

Jpn J Antibiot. 2003 Oct;56(5):424-36. Japanese.

PMID:
14692379
49.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). I. Susceptibility distribution].

Kumamoto Y, Tsukamoto T, Watanabe K, Kobayashi Y, Matsukawa M, Uchida H, Kunishima Y, Hirose T, Matsuda S, Sato S, Shigeta S, Fujime M, Fujita K, Yamaguti O, Ogihara M, Ishibashi K, Igari J, Takahashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Furuya N, Kashitani F, Murai M, Ooe H, Nishikawa M, Kumon H, Monden K, Oka T, Kitamura M, Kohno S, Tomono K, Miyazaki Y, Matsuoka Y, Fukuhara Y, Hirakata Y, Aoki S.

Jpn J Antibiot. 2003 Oct;56(5):396-423. Japanese.

PMID:
14692378
50.

The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.

Kaneko H, Mori S, Suzuki O, Iida T, Shigeta S, Abe M, Ohno S, Aoki K, Suzutani T.

Antiviral Res. 2004 Jan;61(1):63-6.

PMID:
14670595

Supplemental Content

Loading ...
Support Center